nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ADRA1A—polycystic ovary syndrome	0.761	1	CbGaD
Trazodone—HTR2A—urine—polycystic ovary syndrome	0.00226	0.0638	CbGeAlD
Trazodone—CYP3A4—urine—polycystic ovary syndrome	0.00209	0.059	CbGeAlD
Trazodone—CYP2D6—urine—polycystic ovary syndrome	0.00206	0.0581	CbGeAlD
Trazodone—Sinus congestion—Metformin—polycystic ovary syndrome	0.00187	0.0977	CcSEcCtD
Trazodone—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00131	0.0371	CbGeAlD
Trazodone—ORM1—endometrium—polycystic ovary syndrome	0.00119	0.0335	CbGeAlD
Trazodone—HTR2B—adrenal cortex—polycystic ovary syndrome	0.00112	0.0316	CbGeAlD
Trazodone—HTR2B—endometrium—polycystic ovary syndrome	0.001	0.0282	CbGeAlD
Trazodone—Ziprasidone—ADRA1B—polycystic ovary syndrome	0.000973	0.104	CrCbGaD
Trazodone—HTR2B—uterus—polycystic ovary syndrome	0.000923	0.026	CbGeAlD
Trazodone—HTR2B—adipose tissue—polycystic ovary syndrome	0.000902	0.0255	CbGeAlD
Trazodone—Lightheadedness—Metformin—polycystic ovary syndrome	0.000832	0.0435	CcSEcCtD
Trazodone—ORM1—endocrine gland—polycystic ovary syndrome	0.000831	0.0234	CbGeAlD
Trazodone—Nefazodone—ADRA1B—polycystic ovary syndrome	0.000818	0.0875	CrCbGaD
Trazodone—HTR2B—adrenal gland—polycystic ovary syndrome	0.000809	0.0228	CbGeAlD
Trazodone—Aripiprazole—ADRA1B—polycystic ovary syndrome	0.00076	0.0813	CrCbGaD
Trazodone—HTR2B—vagina—polycystic ovary syndrome	0.00075	0.0212	CbGeAlD
Trazodone—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000745	0.021	CbGeAlD
Trazodone—Nasal congestion—Metformin—polycystic ovary syndrome	0.000741	0.0388	CcSEcCtD
Trazodone—HTR2A—embryo—polycystic ovary syndrome	0.000731	0.0206	CbGeAlD
Trazodone—HTR1A—adrenal gland—polycystic ovary syndrome	0.000725	0.0205	CbGeAlD
Trazodone—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.000721	0.0771	CrCbGaD
Trazodone—SLC6A4—endocrine gland—polycystic ovary syndrome	0.000708	0.02	CbGeAlD
Trazodone—Lethargy—Metformin—polycystic ovary syndrome	0.000689	0.036	CcSEcCtD
Trazodone—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000669	0.0189	CbGeAlD
Trazodone—Migraine—Metformin—polycystic ovary syndrome	0.000665	0.0348	CcSEcCtD
Trazodone—Ziprasidone—ADRA1A—polycystic ovary syndrome	0.000655	0.0701	CrCbGaD
Trazodone—HRH1—endometrium—polycystic ovary syndrome	0.00064	0.0181	CbGeAlD
Trazodone—HTR1A—endocrine gland—polycystic ovary syndrome	0.000629	0.0177	CbGeAlD
Trazodone—ADRA2A—endometrium—polycystic ovary syndrome	0.000629	0.0177	CbGeAlD
Trazodone—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000594	0.0168	CbGeAlD
Trazodone—ADRA1A—endocrine gland—polycystic ovary syndrome	0.00058	0.0164	CbGeAlD
Trazodone—ADRA2A—uterus—polycystic ovary syndrome	0.000579	0.0163	CbGeAlD
Trazodone—HRH1—adipose tissue—polycystic ovary syndrome	0.000577	0.0163	CbGeAlD
Trazodone—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000569	0.0161	CbGeAlD
Trazodone—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000567	0.016	CbGeAlD
Trazodone—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00056	0.0293	CcSEcCtD
Trazodone—Quetiapine—ADRA1D—polycystic ovary syndrome	0.000557	0.0596	CrCbGaD
Trazodone—Zuclopenthixol—ADRA1A—polycystic ovary syndrome	0.000554	0.0592	CrCbGaD
Trazodone—Nefazodone—ADRA1A—polycystic ovary syndrome	0.00055	0.0589	CrCbGaD
Trazodone—Drowsiness—Metformin—polycystic ovary syndrome	0.00052	0.0272	CcSEcCtD
Trazodone—HRH1—adrenal gland—polycystic ovary syndrome	0.000518	0.0146	CbGeAlD
Trazodone—Aripiprazole—ADRA1A—polycystic ovary syndrome	0.000512	0.0548	CrCbGaD
Trazodone—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000508	0.0143	CbGeAlD
Trazodone—CYP3A5—female gonad—polycystic ovary syndrome	0.000497	0.014	CbGeAlD
Trazodone—CYP3A5—vagina—polycystic ovary syndrome	0.000494	0.0139	CbGeAlD
Trazodone—Loxapine—ADRA1B—polycystic ovary syndrome	0.000487	0.0521	CrCbGaD
Trazodone—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.000485	0.0519	CrCbGaD
Trazodone—HTR2A—pituitary gland—polycystic ovary syndrome	0.000484	0.0136	CbGeAlD
Trazodone—HRH1—female gonad—polycystic ovary syndrome	0.000483	0.0136	CbGeAlD
Trazodone—HRH1—vagina—polycystic ovary syndrome	0.00048	0.0135	CbGeAlD
Trazodone—ABCB1—embryo—polycystic ovary syndrome	0.000479	0.0135	CbGeAlD
Trazodone—Bradycardia—Metformin—polycystic ovary syndrome	0.000476	0.0249	CcSEcCtD
Trazodone—Quetiapine—ADRA1B—polycystic ovary syndrome	0.000475	0.0508	CrCbGaD
Trazodone—ADRA2A—female gonad—polycystic ovary syndrome	0.000474	0.0134	CbGeAlD
Trazodone—ADRA2A—vagina—polycystic ovary syndrome	0.000471	0.0133	CbGeAlD
Trazodone—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000465	0.0243	CcSEcCtD
Trazodone—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000462	0.013	CbGeAlD
Trazodone—HRH1—endocrine gland—polycystic ovary syndrome	0.000449	0.0127	CbGeAlD
Trazodone—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000441	0.0124	CbGeAlD
Trazodone—Flushing—Metformin—polycystic ovary syndrome	0.000434	0.0227	CcSEcCtD
Trazodone—HTR2A—adrenal gland—polycystic ovary syndrome	0.000432	0.0122	CbGeAlD
Trazodone—Chills—Metformin—polycystic ovary syndrome	0.000419	0.0219	CcSEcCtD
Trazodone—Clozapine—ADRA1B—polycystic ovary syndrome	0.000409	0.0437	CrCbGaD
Trazodone—Flatulence—Metformin—polycystic ovary syndrome	0.000401	0.021	CcSEcCtD
Trazodone—HTR2A—vagina—polycystic ovary syndrome	0.000401	0.0113	CbGeAlD
Trazodone—Dysgeusia—Metformin—polycystic ovary syndrome	0.000398	0.0208	CcSEcCtD
Trazodone—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000392	0.0111	CbGeAlD
Trazodone—Vision blurred—Metformin—polycystic ovary syndrome	0.000383	0.02	CcSEcCtD
Trazodone—Tremor—Metformin—polycystic ovary syndrome	0.000381	0.0199	CcSEcCtD
Trazodone—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000377	0.0197	CcSEcCtD
Trazodone—HTR2A—endocrine gland—polycystic ovary syndrome	0.000375	0.0106	CbGeAlD
Trazodone—CYP2D6—female gonad—polycystic ovary syndrome	0.000367	0.0104	CbGeAlD
Trazodone—Malaise—Metformin—polycystic ovary syndrome	0.000367	0.0192	CcSEcCtD
Trazodone—Syncope—Metformin—polycystic ovary syndrome	0.000365	0.0191	CcSEcCtD
Trazodone—Palpitations—Metformin—polycystic ovary syndrome	0.000359	0.0188	CcSEcCtD
Trazodone—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000357	0.0187	CcSEcCtD
Trazodone—Hypertension—Metformin—polycystic ovary syndrome	0.000351	0.0184	CcSEcCtD
Trazodone—ABCB1—endometrium—polycystic ovary syndrome	0.00035	0.00988	CbGeAlD
Trazodone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000347	0.00979	CbGeAlD
Trazodone—Chest pain—Metformin—polycystic ovary syndrome	0.000346	0.0181	CcSEcCtD
Trazodone—Myalgia—Metformin—polycystic ovary syndrome	0.000346	0.0181	CcSEcCtD
Trazodone—Discomfort—Metformin—polycystic ovary syndrome	0.000342	0.0179	CcSEcCtD
Trazodone—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000341	0.00963	CbGeAlD
Trazodone—Oedema—Metformin—polycystic ovary syndrome	0.000332	0.0174	CcSEcCtD
Trazodone—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.00033	0.0353	CrCbGaD
Trazodone—Loxapine—ADRA1A—polycystic ovary syndrome	0.000328	0.0351	CrCbGaD
Trazodone—Shock—Metformin—polycystic ovary syndrome	0.000327	0.0171	CcSEcCtD
Trazodone—ABCB1—uterus—polycystic ovary syndrome	0.000323	0.00911	CbGeAlD
Trazodone—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000321	0.0168	CcSEcCtD
Trazodone—Quetiapine—ADRA1A—polycystic ovary syndrome	0.00032	0.0342	CrCbGaD
Trazodone—ABCB1—pituitary gland—polycystic ovary syndrome	0.000317	0.00894	CbGeAlD
Trazodone—Anorexia—Metformin—polycystic ovary syndrome	0.000316	0.0165	CcSEcCtD
Trazodone—ABCB1—adipose tissue—polycystic ovary syndrome	0.000316	0.00891	CbGeAlD
Trazodone—Hypotension—Metformin—polycystic ovary syndrome	0.00031	0.0162	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000302	0.0158	CcSEcCtD
Trazodone—Paraesthesia—Metformin—polycystic ovary syndrome	0.000298	0.0156	CcSEcCtD
Trazodone—Dyspnoea—Metformin—polycystic ovary syndrome	0.000296	0.0155	CcSEcCtD
Trazodone—Somnolence—Metformin—polycystic ovary syndrome	0.000295	0.0154	CcSEcCtD
Trazodone—Decreased appetite—Metformin—polycystic ovary syndrome	0.000289	0.0151	CcSEcCtD
Trazodone—Fatigue—Metformin—polycystic ovary syndrome	0.000286	0.015	CcSEcCtD
Trazodone—Constipation—Metformin—polycystic ovary syndrome	0.000284	0.0148	CcSEcCtD
Trazodone—ABCB1—adrenal gland—polycystic ovary syndrome	0.000283	0.00799	CbGeAlD
Trazodone—Clozapine—ADRA1A—polycystic ovary syndrome	0.000275	0.0294	CrCbGaD
Trazodone—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000274	0.0143	CcSEcCtD
Trazodone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000271	0.0142	CcSEcCtD
Trazodone—ABCB1—female gonad—polycystic ovary syndrome	0.000264	0.00745	CbGeAlD
Trazodone—Urticaria—Metformin—polycystic ovary syndrome	0.000264	0.0138	CcSEcCtD
Trazodone—ABCB1—vagina—polycystic ovary syndrome	0.000263	0.0074	CbGeAlD
Trazodone—Abdominal pain—Metformin—polycystic ovary syndrome	0.000262	0.0137	CcSEcCtD
Trazodone—ABCB1—endocrine gland—polycystic ovary syndrome	0.000246	0.00693	CbGeAlD
Trazodone—Asthenia—Metformin—polycystic ovary syndrome	0.000238	0.0124	CcSEcCtD
Trazodone—Pruritus—Metformin—polycystic ovary syndrome	0.000235	0.0123	CcSEcCtD
Trazodone—Diarrhoea—Metformin—polycystic ovary syndrome	0.000227	0.0119	CcSEcCtD
Trazodone—Dizziness—Metformin—polycystic ovary syndrome	0.00022	0.0115	CcSEcCtD
Trazodone—Vomiting—Metformin—polycystic ovary syndrome	0.000211	0.011	CcSEcCtD
Trazodone—Rash—Metformin—polycystic ovary syndrome	0.000209	0.0109	CcSEcCtD
Trazodone—Dermatitis—Metformin—polycystic ovary syndrome	0.000209	0.0109	CcSEcCtD
Trazodone—Headache—Metformin—polycystic ovary syndrome	0.000208	0.0109	CcSEcCtD
Trazodone—Nausea—Metformin—polycystic ovary syndrome	0.000197	0.0103	CcSEcCtD
Trazodone—Clozapine—CYP1A1—polycystic ovary syndrome	0.00014	0.015	CrCbGaD
Trazodone—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	1.64e-05	9.36e-05	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.63e-05	9.35e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.63e-05	9.34e-05	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.62e-05	9.3e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.62e-05	9.28e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	1.61e-05	9.23e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	1.61e-05	9.22e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.6e-05	9.18e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.6e-05	9.15e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.59e-05	9.1e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.56e-05	8.93e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—TH—polycystic ovary syndrome	1.56e-05	8.92e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.55e-05	8.89e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.55e-05	8.86e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	1.54e-05	8.84e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.54e-05	8.83e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.54e-05	8.81e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	1.54e-05	8.79e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	1.54e-05	8.79e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	1.53e-05	8.76e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.53e-05	8.76e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.53e-05	8.73e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.52e-05	8.72e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.52e-05	8.72e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.52e-05	8.7e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.52e-05	8.7e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	1.52e-05	8.68e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.51e-05	8.66e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.51e-05	8.62e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.49e-05	8.54e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.49e-05	8.54e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	1.49e-05	8.53e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.48e-05	8.49e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.48e-05	8.44e-05	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.47e-05	8.4e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.47e-05	8.38e-05	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.46e-05	8.38e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.46e-05	8.36e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	1.46e-05	8.34e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.45e-05	8.32e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.45e-05	8.31e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.45e-05	8.3e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.45e-05	8.28e-05	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.44e-05	8.23e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.43e-05	8.17e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	1.43e-05	8.16e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.43e-05	8.16e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.42e-05	8.15e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.42e-05	8.11e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.41e-05	8.1e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.41e-05	8.08e-05	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.41e-05	8.07e-05	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.41e-05	8.06e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.39e-05	7.95e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.39e-05	7.94e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.39e-05	7.93e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.39e-05	7.93e-05	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.38e-05	7.91e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.38e-05	7.9e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.38e-05	7.9e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	1.36e-05	7.77e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.36e-05	7.76e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.35e-05	7.75e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	1.35e-05	7.71e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.34e-05	7.68e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.34e-05	7.67e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.34e-05	7.66e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.34e-05	7.65e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.34e-05	7.64e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.33e-05	7.63e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.33e-05	7.62e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.33e-05	7.61e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	1.33e-05	7.61e-05	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	1.33e-05	7.6e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	1.33e-05	7.59e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.32e-05	7.57e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.31e-05	7.52e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—LEP—polycystic ovary syndrome	1.31e-05	7.49e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	1.31e-05	7.48e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.31e-05	7.47e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.3e-05	7.45e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.29e-05	7.38e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.29e-05	7.38e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.28e-05	7.35e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.28e-05	7.34e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.28e-05	7.33e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.28e-05	7.32e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.28e-05	7.32e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	1.27e-05	7.28e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.27e-05	7.24e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.27e-05	7.24e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.26e-05	7.23e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.26e-05	7.22e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	1.26e-05	7.21e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.26e-05	7.2e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.25e-05	7.18e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.25e-05	7.13e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.24e-05	7.07e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.23e-05	7.04e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.22e-05	6.98e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.21e-05	6.94e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	1.21e-05	6.94e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	1.21e-05	6.92e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.19e-05	6.82e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.17e-05	6.72e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.17e-05	6.71e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.17e-05	6.69e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IRS1—polycystic ovary syndrome	1.17e-05	6.68e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.17e-05	6.68e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	1.17e-05	6.67e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.17e-05	6.67e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	1.15e-05	6.58e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.15e-05	6.57e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.15e-05	6.55e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—POMC—polycystic ovary syndrome	1.12e-05	6.43e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—INS—polycystic ovary syndrome	1.12e-05	6.4e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.11e-05	6.38e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.11e-05	6.36e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	1.11e-05	6.36e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	1.1e-05	6.3e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.09e-05	6.26e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.09e-05	6.25e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.09e-05	6.24e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	1.09e-05	6.22e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.08e-05	6.21e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.08e-05	6.19e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.08e-05	6.18e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—INS—polycystic ovary syndrome	1.08e-05	6.18e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	1.08e-05	6.17e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.08e-05	6.17e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	1.07e-05	6.13e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.07e-05	6.13e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.07e-05	6.12e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.06e-05	6.09e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.06e-05	6.07e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	1.06e-05	6.04e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	1.05e-05	6.03e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.05e-05	6e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.05e-05	5.98e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.03e-05	5.88e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.02e-05	5.81e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.01e-05	5.8e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.01e-05	5.8e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	9.95e-06	5.69e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	9.88e-06	5.65e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	9.86e-06	5.64e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	9.82e-06	5.62e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	9.47e-06	5.42e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	9.42e-06	5.39e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	9.37e-06	5.36e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	9.35e-06	5.35e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	9.32e-06	5.33e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	9.29e-06	5.32e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	9.17e-06	5.25e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	9.17e-06	5.25e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	9.15e-06	5.23e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	9.12e-06	5.22e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	9.07e-06	5.19e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	9.06e-06	5.19e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	9.03e-06	5.17e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	9.02e-06	5.16e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	8.98e-06	5.14e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	8.8e-06	5.04e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	8.77e-06	5.02e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	8.76e-06	5.01e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	8.72e-06	4.99e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	8.72e-06	4.99e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	8.7e-06	4.98e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	8.69e-06	4.97e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	8.57e-06	4.9e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.52e-06	4.88e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—INS—polycystic ovary syndrome	8.52e-06	4.88e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	8.38e-06	4.8e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	8.36e-06	4.78e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	8.34e-06	4.77e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.33e-06	4.77e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	8.29e-06	4.75e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.28e-06	4.74e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	8.27e-06	4.73e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.26e-06	4.72e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	8.18e-06	4.68e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	8.16e-06	4.67e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	8.01e-06	4.58e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	7.96e-06	4.56e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	7.95e-06	4.55e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	7.9e-06	4.52e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	7.87e-06	4.51e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	7.86e-06	4.5e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	7.85e-06	4.49e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	7.83e-06	4.48e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	7.81e-06	4.47e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—INS—polycystic ovary syndrome	7.81e-06	4.47e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7.8e-06	4.46e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	7.71e-06	4.41e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	7.68e-06	4.39e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	7.67e-06	4.39e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	7.57e-06	4.33e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	7.57e-06	4.33e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	7.56e-06	4.33e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	7.55e-06	4.32e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	7.49e-06	4.29e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.44e-06	4.26e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	7.42e-06	4.24e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	7.41e-06	4.24e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	7.41e-06	4.24e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.19e-06	4.12e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.18e-06	4.11e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	7.16e-06	4.1e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	7.12e-06	4.08e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.06e-06	4.04e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.04e-06	4.03e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	6.98e-06	4e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.89e-06	3.94e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.89e-06	3.94e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	6.71e-06	3.84e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	6.67e-06	3.82e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	6.64e-06	3.8e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.54e-06	3.75e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	6.46e-06	3.7e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.07e-06	3.48e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	6.01e-06	3.44e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—POMC—polycystic ovary syndrome	5.92e-06	3.39e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—INS—polycystic ovary syndrome	5.89e-06	3.37e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.79e-06	3.32e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.78e-06	3.31e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.73e-06	3.28e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.7e-06	3.26e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.67e-06	3.25e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.66e-06	3.24e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	5.58e-06	3.2e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.55e-06	3.18e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.42e-06	3.1e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.27e-06	3.02e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.16e-06	2.96e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.95e-06	2.83e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.94e-06	2.83e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.9e-06	2.8e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	4.88e-06	2.8e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.84e-06	2.77e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.56e-06	2.61e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.5e-06	2.58e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.96e-06	2.27e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	3.94e-06	2.26e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.7e-06	2.12e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.65e-06	2.09e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.63e-06	2.08e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	3.42e-06	1.96e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	3.41e-06	1.95e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.35e-06	1.92e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	3.11e-06	1.78e-05	CbGpPWpGaD
